e_Buah Biblioteca Digital Universidad de Alcalá
Publication
Artículo científico (JournalArticle)
Integrin-Linked Kinase (ILK) promotes mitochondrial dysfunction by decreasing CPT1A expression in a folic acid-based model of kidney disease
21 p., Integrin-linked kinase (ILK) is a key scaffolding protein between extracellular matrix protein and the cytoskeleton and has been implicated previously in the pathogenesis of renal damage. However, its involvement in renal mitochondrial dysfunction remains to be elucidated. We studied the role of ILK and its downstream regulations in renal damage and mitochondria function both in vivo and vitro, using a folic acid (FA)induced kidney disease model. Wild type (WT) and ILK conditional-knockdown (cKDILK) mice were injected with a single intraperitoneal dose of FA and studied after 15 days of chronic renal damage progression. Human Kidney tubular epithelial cells (HK2) were transfected with specific siRNAs targeting ILK, glycogen synthase kinase 3-? (GSK3?), or CCAAT/enhancer binding protein-? (C/EBP?). The expressions and activities of renal ILK, GSK3?, C/EBP?, mitochondrial oxidative phosphorylation enzymes, and mitochondrial membrane potential were assessed. Additionally, the expression of markers for fibrosis fibronectin (FN) and collagen 1 (COL1A1), for autophagy p62 and cytosolic light chain 3 (LC3B) isoforms II and I, and mitochondrial homeostasis marker carnitine palmitoyl-transferase 1A (CPT1A) were evaluated using immunoblotting, RT-qPCR, immunofluorescence, or colorimetric assays. FA upregulated ILK expression, leading to the decrease of GSK3? activity, increased tubular fibrosis, and produced mitochondrial dysfunction, both in vivo and vitro. These alterations were fully or partially reversed upon ILK depletion, mitigating FA-induced renal damage. The signaling axis composed by ILK, GSK3?, and C/EBP? regulated CPT1A transcription as the limiting factor in the FA-based impaired mitochondrial activity. We highlight ILK as a potential therapeutical target for preserving mitochondrial function in kidney injury., Instituto de Salud Carlos III, Comunidad de Madrid, Universidad de Alcalá, Fondo Europeo de Desarrollo Regional (FEDER)
Project:
ISCIII / Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 (ISCIII) PI17/01513
,
ISCIII / Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 (ISCIII) PI17/00625
,
ISCIII / acción estratégica en salud 2017-2020 (ISCIII) PI20/00634
,
ISCIII / acción estratégica en salud 2017-2020 (ISCIII) PI20/00664
,
ISCIII / Not available PI22/01714
,
ISCIII / Not available PI23/01071
,
Comunidad de Madrid / Not available P2022/BMD7221
,
Comunidad de Madrid / Not available B2017/BMD3751
,
ISCIII / Not available RD24/0004/0020
,
ISCIII / Not available RD21/0005/0023
,
Comunidad de Madrid / Not available S2022/BMD-7221
,
UAH / Not available PIUAH232%FCCS-010